In both children and adults, the drug allows for decreasing glucocorticoid dosing to physiological levels while still ...

Surveillance endoscopy conducted every 2 years for Barrett’s esophagus offers no benefit in overall survival compared with ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Just 25 years ago, venous thromboembolism treatment regimens were primitive, writes Dr Holley. But two trials showed that apixaban and rivaroxaban are proving excellent options for tackling VTE.

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

Knowledge gaps are leading to delayed diagnoses. Now, specialized centers are not only managing complex cases but are also ...

The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

The US Food and Drug Administration (FDA) has approved belzutifan (Welireg, Merck) for adult and pediatric patients aged 12 ...

Motivated by what they see as politicized attacks on science and public health, some physicians are running for office.

About one quarter of all US children lived with a parent with SUD in 2023; one third of these children have parents with ...

Researchers have linked diet-induced inflammation to a higher risk for fatty pancreas in patients with common bile duct ...